MiR-34a overexpression enhances the inhibitory effect of doxorubicin on HepG2 cells

BACKGROUND: Hepatocellular carcinoma (HCC) is the third leading cause of death from malignant tumors worldwide. More than 50% of HCC cases occur in China. The prognosis remains poor and overall efficacy is still unsatisfactory. Chemotherapy resistance is the most important reason for the poor outcom...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Shun-Zhen, Sun, Ping, Wang, Jian-Ping, Liu, Yong, Gong, Wei, Liu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580351/
https://www.ncbi.nlm.nih.gov/pubmed/31235998
http://dx.doi.org/10.3748/wjg.v25.i22.2752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580351/
https://www.ncbi.nlm.nih.gov/pubmed/31235998
http://dx.doi.org/10.3748/wjg.v25.i22.2752

Ejemplares similares